Myriad Genetics partners with AWS to enhance Image Genius, speeding up document processing, and improving insurance workflows ...
MarketBeat on MSN
SOPHiA GENETICS Q2 earnings call highlights
Key Points Interested in SOPHiA GENETICS SA? Here are five stocks we like better. Q2 revenue rose 27% to $23.3 million, while ...
How readily a cell divides and how well it survives are fundamental to life, shaping everything from organ size to the body's ...
Researchers created a cell village culture system and Townlet algorithm to map genetic drivers of brain cell growth, 16p11.2 ...
View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.
Topline six-month efficacy data expected by end of 2027 Phase 3 study follows FDA alignment on registrational trial design through Rare Disease Evidence Principles (RDEP) program Opus Genetics may sub ...
Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% decrease in average revenue per test year-over-year. The company is engaging ...
Myriad Genetics lowered its full-year revenue guidance, as second quarter sales fell due to volume challenges in prenatal health and increased payer friction. The genetic testing and precision ...
According to MarketsandMarkets, the Animal Genetics Market is projected to reach USD 9.37 billion by 2031 from USD 6.64 billion in 2026, at ...
Myriad Genetics (NASDAQ:MYGN) reported second-quarter 2026 revenue of $190.7 million, down 11% from a year earlier, as a 1% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results